Cargando…
Corrigendum to: Association of Biomarker Cutoffs and Endoscopic Outcomes in Crohn’s Disease: a Post Hoc Analysis From the CALM Study
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314100/ https://www.ncbi.nlm.nih.gov/pubmed/33999130 http://dx.doi.org/10.1093/ibd/izab079 |
Ejemplares similares
-
Association of Biomarker Cutoffs and Endoscopic Outcomes in Crohn’s Disease: A Post Hoc Analysis From the CALM Study
por: Reinisch, Walter, et al.
Publicado: (2020) -
Corrigendum to: Pharmacokinetic-Pharmacodynamic Model of Vedolizumab for Targeting Endoscopic Remission in Patients with Crohn Disease: Posthoc Analysis of the LOVE-CD Study
por: Hanzel, Jurij, et al.
Publicado: (2021) -
Corrigendum to Crohn’s Disease Patient Infected With Multiple Co-occurring Nontuberculous Mycobacteria
por: Hala, Sharif, et al.
Publicado: (2020) -
Corrigendum to: Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn’s Disease
Publicado: (2021) -
Corrigendum: Polymorphisms in the Mannose-Binding Lectin Gene are Associated with Defective Mannose-Binding Lectin Functional Activity in Crohn’s Disease Patients
por: Choteau, Laura, et al.
Publicado: (2016)